New label revisions and warnings from the FDA

被引：0

|

作者：

Aschenbrenner, Diane S. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA

来源：

AMERICAN JOURNAL OF NURSING | 2007年 / 107卷 / 04期

关键词：

D O I：

10.1097/01.NAJ.0000271173.36704.92

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：27 / 28

页数：2

相关论文

共 50 条

[1] Label revisions: New contraindications and warnings
Aschenbrenner, Diane S.
[J]. AMERICAN JOURNAL OF NURSING, 2007, 107 (08) : 33 - 33
[2] FDA wants warnings on Enbrel label
[J]. Reactions Weekly, 2008, 1208 (1) : 2 - 2
[3] FDA lifts pregnancy-related warnings from lubiprostone label
[J]. Reactions Weekly, 2013, 1433 (1) : 3 - 3
[4] The FDA and New Safety Warnings
Moore, Thomas J.
Singh, Sonal
Furberg, Curt D.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (01) : 78 - 80
[5] FDA WANTS LABEL WARNINGS ABOUT ANTIPARASITIC RESISTANCE
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2019, 254 (04): : 443 - 443
[6] FDA rejects industry requests for food label revisions
不详
[J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1999, 99 (10) : 1206 - 1206
[7] New and incremental FDA black box warnings from 2008 to 2015
Solotke, Michael T.
Dhruva, Sanket S.
Downing, Nicholas S.
Shah, Nilay D.
Ross, Joseph S.
[J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 117 - 123
[8] FDA briefs - New warnings and indications.
不详
[J]. AMERICAN JOURNAL OF NURSING, 2006, 106 (07) : 30 - 31
[9] FDA requests inclusion of new warnings for ADHD medications
Ralat, Jose
[J]. CNS SPECTRUMS, 2006, 11 (10) : 739 - 739
[10] New label warnings required for atypical antipsychotics
不详
[J]. GERIATRIC NURSING, 2004, 25 (02) : 70 - 70

← 1 2 3 4 5 →